Adderall XR
Active substance: DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AMPHETAMINE SULFATE
CAPSULE, EXTENDED RELEASE · DEXTROAMPHETAMINE SULFATE 7.5 mg/1, DEXTROAMPHETAMINE SACCHARATE 7.5 mg/1, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1, AMPHETAMINE SULFATE 7.5 mg/1
United StatesActive
Marketing holder: Takeda Pharmaceuticals America, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEXTROAMPHETAMINE SULFATE · 7.5 mg/1
- DEXTROAMPHETAMINE SACCHARATE · 7.5 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE · 7.5 mg/1
- AMPHETAMINE SULFATE · 7.5 mg/1
Import and control
Control by country
- United StatescontrolledSchedule: CII
Source: openFDA NDC · record 01a1208c-2969-7aff-be90-3e61f4361cd1,01a1208c-3058-7a63-b534-18d99609d992,01a1208c-3059-794c-84a4-e5e28aefc09f,01a1208c-4801-7a7b-aa2e-f8fa24548a4b,01a1208c-519c-73b0-8f5f-65c55690e4b3;count=62 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 54092-391
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CII
- Route
- ORAL
Sources
- product · openFDA NDC · 54092-391 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 54092-391 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 54092-391 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 54092-391 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 54092-391 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 54092-391 · Verified 2026-10-09 · open in source